NANEMIAR are participating in the European Hematology Association Congress (EHA 2026), one of the most important international scientific meetings in the field of hematology.

Dr. Perez-Oliva was invited as a speaker in today's session, "Inflammasome in Congenital Anemias", where she delivered a presentation entitled "Inflammasome and Its Implications in the Pathogenesis of the Disease." During her talk, she provided an overview of the laboratory's most relevant ongoing projects and recent findings.

Clinicians from the Virgen de la Arrixaca University Clinical Hospital (HCUVA) involved in each of OCAILAB's research projects also attended the meeting.

The congress brings together researchers, clinicians, and healthcare professionals from around the world to present and discuss the latest advances in the study of blood disorders, as well as novel diagnostic and therapeutic strategies.

Participation in EHA 2026 provides an excellent opportunity to showcase the work carried out by NANEMIAR, establish new scientific collaborations, and stay up to date with the innovations shaping the future of hematology research.

From Stockholm, we remain committed to excellence in research, contributing to the generation of knowledge and the improvement of patients' quality of life.